N/A
N=41
American Sign Language-Accessible Diabetes Education
Diabetes · Deafness
Bottom Line
View on ClinicalTrials.gov: NCT03980808 ↗Enrolled (actual)
41
Serious AEs
0.0%
Results posted
Sep 2022
Primary outcome: Primary: Diabetes Health Literacy Score — 1.30; 1.38 score on a scale — p=0.95
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- American Sign Language-Accessible Diabetes Education (Behavioral); Control Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Georgia Institute of Technology
- Primary completion
- Jan 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diabetes Health Literacy Score |
1.30; 1.38 | 0.95 |
| PRIMARY Frequency of Engagement in Diabetes-Related Health Behaviors |
.2381; 2.0625 | 0.093 |
Summary
ASL-ADE will evaluate the efficacy of an ASL-interpreted diabetes educational intervention to the end of improving the health literacy of the target population and addressing their disparate health outcomes.
Eligibility Criteria
Inclusion Criteria
- 18 years old or older
- Deaf
- Primary language is American Sign Language
- Approximately one-half of the sample must have a diabetes diagnosis.
Exclusion Criteria
- Minors
- People whose primary language is not ASL
- Individuals unable to provide consent due to impaired decision-making
Data sourced from ClinicalTrials.gov (NCT03980808). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.